2018 Cell Surface Markers: US, Europe, Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

I. Introduction
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8
Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
Drew-Scientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls

G. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. France : Forecasts by Test and Market Segment

IV. Germany : Forecasts by Test and Market Segment
V. Italy : Forecasts by Test and Market Segment

VI. Japan : Forecasts by Test and Market Segment
VII. Spain : Forecasts by Test and Market Segment

VIII. U.K. : Forecasts by Test and Market Segment
IX. U.S. : Forecasts by Test and Market Segment

X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor

XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Dako/Agilent Technologies
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex

List Of Tables

France, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated
Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume


U.S., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated
Cell Surface Marker Test Volume


Global Blood Plasma Products Market (2018-2023)

Global Blood Plasma Products Market (2018-2023) market research report available in single user pdf license with Aarkstore Enterprise at USD 2950

USD 2950 View Report

Global Neurosurgery Software Market Size study, by Type (Preoperative Planning Software, Recording Software, Visualization Software, Analysis Software, Others), by Application (Functional Neurosurgery, Endoscopic Surgery, Open Skull Surgery) and Regional Forecasts 2018-2025

Global Neurosurgery Software Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025.

USD 3950 View Report

Cell Surface Markers, 2019-2023: US, Europe, Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination

USD 4850 View Report

Cell Surface Marker Detection Market Size, Outlook and Growth Opportunities, 2019- 2025

Global Cell Surface Marker Detection Market Size, Outlook and Growth Opportunities to 2025: By Product (Antibodies, PCR Arrays), By Source (Mice, Rats, and Others), By Application (Research Applications, Clinical Applications),

USD 4580 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available